Global Molecular Diagnostics (MDx) Point of Care Market Analysis, 2020

Growing Infectious respiratory diseases, STDs to boost global MDx Point of Care Market

Global Molecular Diagnostics (MDx) Point of Care Market Analysis, 2020 research report depicts a deep-dive market analysis of statistics of Global Molecular Diagnostics (MDx) Point of Care market which consists of regional and country-wise market size, market forecast, CAGR market segmentation, market shares of diverse regions and countries, market share of various end users, applications, product type, technologies, competitive benchmarking, etc.

The prevalence of diseases such as infectious diseases in developing countries as well as less developed countries is surging due to improving healthcare infrastructure and the preference of patients for efficient home care. Moreover, suitable government norms and extensive support are also helping in the market growth of MDx Point of Care market. According to this research report titled “Global Molecular Diagnostics (MDx) Point of Care Market Analysis, 2020”, the Global Molecular Diagnostics (MDx) Point of Care market is anticipated to grow at a CAGR of around 13% during 2020-25. However, a lack of arrangement with test results obtained from laboratories, strict & tedious approval policies are expected to restrain the market growth.

Assays are expected to grab the largest market share in the Global Molecular Diagnostics Point of Care market during 2020-25. The assays are uniquely intended for points of care such as hospital critical care units, Specialty clinics, and other healthcare services delivery centers.

North America dominated the Global Mdx Point of Care market in 2019. The same trend is set to prevail during the forecast period. However, the year-on-year growth of Asia-Pacific is set to outperform other geographies during the same period. The region is forecast to grow at a CAGR of around 15.89% during 2020-25, as stated in the research report “Global Molecular Diagnostics (MDx) Point of Care Market Analysis, 2020”.

According to the publisher, Abbott Laboratories, Mesa Biotech, Hologic, Qiagen, F. Hoffmann, Siemens Healthineers, DxNA, Johnson & Johnson, Roche Diagnostics, Danaher Corporation, EKF Diagnostics, Becton Dickinson, Trinty Biotech, and Quidel are few of the leading players in the Global Molecular Diagnostics (MDx) Point of Care Market.

Key Questions Answered in the Market Research Report

1. What are the key overall market statistics or market estimates (Market Overview, Market Size- By Value, Forecast, Market Segmentation, Market Shares) of Global Molecular Diagnostics (MDx) Point of Care Market?
2. What are the region wise industry size, growth drivers and challenges key market trends?
3. What are the key innovations, technology upgrades, opportunities, regulations in the Global Molecular Diagnostics (MDx) Point of Care Market?
4. Who are the key competitors or market players and how they perform in Global Molecular Diagnostics (MDx) Point of Care Market on the basis of competitive benchmarking matrix?
5. What are the key results derived from the market surveys conducted during the course of Global Molecular Diagnostics (MDx) Point of Care Market study?

1. Introduction

1.1. Product Definition
1.2. Research Process
1.3. Glossary
1.4. Market Segmentation

2. Executive Summary3. Start-up Ecosystem4. Expert Verbatim- Interview Excerpts of 10 industry experts

5. Global Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F

5.1. Market Size & Analysis
5.1.1. By Revenues
5.2. Market Share & Analysis
5.2.1. By Application
5.2.1.1. Infectious Diseases
5.2.1.2. Oncology
5.2.1.3. Hematology
5.2.1.4. Prenatal Testing
5.2.1.5. Endocrinology
5.2.1.6. Others
5.2.2. By Technology
5.2.2.1. Isothermal Nucleic Acid Amplification Technology (INAAT)
5.2.2.2. Polymerase Chain Reaction (PCR)
5.2.2.2.1. Digital PCR
5.2.2.2.2. Real Time PCR
5.2.2.3. Others
5.2.3. By Product
5.2.3.1. Assays
5.2.3.2. Software
5.2.3.3. Services
5.2.4. By Test-Location
5.2.4.1. OTC (Over-the-counter)
5.2.4.2. POC (Point-of-care)
5.2.5. By End-User
5.2.5.1. Decentralized Labs
5.2.5.2. Hospitals
5.2.5.3. Homecare
5.2.5.4. Assisted Living Healthcare Facilities
5.2.5.5. Others
5.2.6. By Region
5.2.6.1. North America
5.2.6.2. South America
5.2.6.3. Europe
5.2.6.4. Asia-Pacific
5.2.6.5. Middle East & Africa
5.2.7. By Company
5.2.7.1. Revenue Shares
5.2.7.2. Strategic Factorial Indexing
5.2.7.3. Competitor Placement in MarkNtel Quadrant

6. North America Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F

6.1. Market Size & Analysis
6.1.1. By Revenues
6.2. Market Share & Analysis
6.2.1. By Application
6.2.2. By Product
6.2.3. By Test-Location
6.2.4. By End-User
6.2.5. By Technology
6.2.6. By Country
6.2.6.1. US
6.2.6.2. Canada
6.2.6.3. Mexico
6.3. US Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
6.3.1. Market Size & Analysis
6.3.1.1. By Revenues
6.3.2. Market Share & Analysis
6.3.2.1. By Application
6.3.2.2. By End-User
6.4. Canada Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
6.4.1. Market Size & Analysis
6.4.1.1. By Revenues
6.4.2. Market Share & Analysis
6.4.2.1. By Application
6.4.2.2. By End-User
6.5. Mexico Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
6.5.1. Market Size & Analysis
6.5.1.1. By Revenues
6.5.2. Market Share & Analysis
6.5.2.1. By Application
6.5.2.2. By End-User

7. South America Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F

7.1. Market Size & Analysis
7.1.1. By Revenues
7.2. Market Share & Analysis
7.2.1. By Application
7.2.2. By Product
7.2.3. By Test-Location
7.2.4. By End-User
7.2.5. By Country
7.2.5.1. Brazil
7.2.5.2. Argentina
7.2.5.3. Others
7.3. Brazil Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
7.3.1. Market Size & Analysis
7.3.1.1. By Revenues
7.3.2. Market Share & Analysis
7.3.2.1. By Application
7.3.2.2. By End-User
7.4. Argentina Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
7.4.1. Market Size & Analysis
7.4.1.1. By Revenues
7.4.2. Market Share & Analysis
7.4.2.1. By Application
7.4.2.2. By End-User

8. Europe Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F

8.1. Market Size & Analysis
8.1.1. By Revenues
8.2. Market Share & Analysis
8.2.1. By Application
8.2.2. By Product
8.2.3. By Test-Location
8.2.4. By End-User
8.2.5. By Technology
8.2.6. By Country
8.2.6.1. The UK
8.2.6.2. Germany
8.2.6.3. France
8.2.6.4. Italy
8.2.6.5. Spain
8.2.6.6. Others
8.3. UK Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
8.3.1. Market Size & Analysis
8.3.1.1. By Revenues
8.3.2. Market Share & Analysis
8.3.2.1. By Application
8.3.2.2. By End-User
8.4. Germany Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
8.4.1. Market Size & Analysis
8.4.1.1. By Revenues
8.4.2. Market Share & Analysis
8.4.2.1. By Application
8.4.2.2. By End-User
8.5. France Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
8.5.1. Market Size & Analysis
8.5.1.1. By Revenues
8.5.2. Market Share & Analysis
8.5.2.1. By Application
8.5.2.2. By End-User
8.6. Italy Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
8.6.1. Market Size & Analysis
8.6.1.1. By Revenues
8.6.2. Market Share & Analysis
8.6.2.1. By Application
8.6.2.2. By End-User
8.7. Spain Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
8.7.1. Market Size & Analysis
8.7.1.1. By Revenues
8.7.2. Market Share & Analysis
8.7.2.1. By Application
8.7.2.2. By End-User

9. Asia-Pacific Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F

9.1. Market Size & Analysis
9.1.1. By Revenues
9.2. Market Share & Analysis
9.2.1. By Application
9.2.2. By Product
9.2.3. By Test-Location
9.2.4. By End-User
9.2.5. By Technology
9.2.6. By Country
9.2.6.1. China
9.2.6.2. India
9.2.6.3. Japan
9.2.6.4. Australia
9.2.6.5. South Korea
9.2.6.6. Others
9.3. China Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
9.3.1. Market Size & Analysis
9.3.1.1. By Revenues
9.3.2. Market Share & Analysis
9.3.2.1. By Application
9.3.2.2. By End-User
9.4. India Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
9.4.1. Market Size & Analysis
9.4.1.1. By Revenues
9.4.2. Market Share & Analysis
9.4.2.1. By Application
9.4.2.2. By End-User
9.5. Japan Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
9.5.1. Market Size & Analysis
9.5.1.1. By Revenues
9.5.2. Market Share & Analysis
9.5.2.1. By Application
9.5.2.2. By End-User
9.6. Australia Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
9.6.1. Market Size & Analysis
9.6.1.1. By Revenues
9.6.2. Market Share & Analysis
9.6.2.1. By Application
9.6.2.2. By End-User
9.7. South Korea Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
9.7.1. Market Size & Analysis
9.7.1.1. By Revenues
9.7.2. Market Share & Analysis
9.7.2.1. By Application
9.7.2.2. By End-User

10. Middle East and Africa Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F

10.1. Market Size & Analysis
10.1.1. By Revenues
10.2. Market Share & Analysis
10.2.1. By Application
10.2.2. By Product
10.2.3. By Test-Location
10.2.4. By End-User
10.2.5. By Technology
10.2.6. By Country
10.2.6.1. UAE
10.2.6.2. Saudi Arabia
10.2.6.3. Others
10.3. UAE Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
10.3.1. Market Size & Analysis
10.3.1.1. By Revenues
10.3.2. Market Share & Analysis
10.3.2.1. By Application
10.3.2.2. By End-User
10.4. Saudi Arabia Molecular Diagnostics (MDx) Point-of-Care Market Outlook, 2015-2025F
10.4.1. Market Size & Analysis
10.4.1.1. By Revenues
10.4.2. Market Share & Analysis
10.4.2.1. By Application
10.4.2.2. By End-User

11. Global Molecular Diagnostics (MDx) Point-of-Care Dynamics

11.1. Drivers
11.2. Challenges
11.3. Impact Analysis

12. Global Molecular Diagnostics (MDx) Point-of-Care Region Wise Regulations, Product Standards13. Global Molecular Diagnostics (MDx) Point-of-Care Hotspots & Opportunities

14. Competition Outlook

14.1. Competitor Wise Growth Strategies
14.1.1. Product Portfolio
14.1.2. Brand Specialization
14.1.3. Target Markets
14.1.4. Research & Development
14.1.5. Strategic Alliances & Initiatives
14.1.6. Merges & Acquisitions
14.2. Company Profiles
14.2.1. Abbott Laboratories
14.2.2. Mesa Biotech
14.2.3. Hologic, Inc.
14.2.4. QIAGEN N.V
14.2.5. F. Hoffmann-La Roche Ltd
14.2.6. DxNA LLC Group Ltd
14.2.7. Luminex Corporation
14.2.8. Siemens Healthineers
14.2.9. Johnson & Johnson
14.2.10. Roche Diagnostics
14.2.11. Danaher Corporation
14.2.12. EKF Diagnostics
14.2.13. Becton Dickison
14.2.14. Trinty Biotech
14.2.15. Quidel Corporation

15. Disclaimer